HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antitumor Activity of 3-Indolylmethanamines 31B and PS121912.

AbstractAIM:
To investigate the in vivo effects of 3-indolylmethanamines 31B and PS121912 in treating ovarian cancer and leukemia, respectively.
MATERIALS AND METHODS:
Terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) and western blotting were applied to demonstrate the induction of apoptosis. Xenografted mice were investigated to show the antitumor effects of 3-indolylmethanamines. (13)C-Nuclear magnetic resource (NMR) and western blotting were used to demonstrate inhibition of glucose metabolism.
RESULTS:
31B inhibited ovarian cancer cell proliferation and activated caspase-3, cleaved poly (ADP-ribose) polymerase 1 (PARP1), and phosphorylated mitogen-activated protein kinases (MAPK), JUN N-terminal kinase/stress-activated protein kinase (JNK/SAPK) and p38. 31B reduced ovarian cancer xenograft tumor growth and PS121912 inhibited the growth of HL-60-derived xenografts without any sign of toxicity. Compound 31B inhibited de novo glycolysis and lipogenesis mediated by the reduction of fatty acid synthase and lactate dehydrogenase-A expression.
CONCLUSION:
3-Indolylmethanamines represent a new class of antitumor agents. We have shown for the first time the in vivo anticancer effects of 3-indolylmethanamines 31B and PS121912.
AuthorsMargaret L Guthrie, Preetpal S Sidhu, Emily K Hill, Timothy C Horan, Premchendar Nandhikonda, Kelly A Teske, Nina Y Yuan, Marina Sidorko, Revathi Rodali, James M Cook, Lanlan Han, Nicholas R Silvaggi, Daniel D Bikle, Richard G Moore, Rakesh K Singh, Leggy A Arnold
JournalAnticancer research (Anticancer Res) Vol. 35 Issue 11 Pg. 6001-7 (Nov 2015) ISSN: 1791-7530 [Electronic] Greece
PMID26504023 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.
Chemical References
  • 4-chloro-N-((2-chlorophenyl)(2-methyl-1H-indol-3-yl)methyl)aniline
  • Amines
  • Aniline Compounds
  • Antineoplastic Agents
  • Hydrocarbons, Aromatic
  • Indoles
  • PS121912
Topics
  • Amines (chemistry)
  • Aniline Compounds (pharmacology)
  • Animals
  • Antineoplastic Agents (pharmacology)
  • Apoptosis (drug effects)
  • Blotting, Western
  • Cell Proliferation (drug effects)
  • Female
  • Flow Cytometry
  • Humans
  • Hydrocarbons, Aromatic (pharmacology)
  • Indoles (chemistry, pharmacology)
  • Magnetic Resonance Spectroscopy
  • Mice
  • Mice, Nude
  • Ovarian Neoplasms (drug therapy, metabolism, pathology)
  • Tumor Cells, Cultured
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: